Mizuho Markets Cayman LP Biogen Inc. Transaction History

Mizuho Markets Cayman LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$252.44 - $306.72 $660,130 - $802,072	2,615 New	2,615 $724,000
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $452,452 - $570,066	-2,335 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$223.92 - $287.77 $853,583 - $1.1 Million	-3,812 Reduced 62.01%	2,335 $560,000
Q3 2021 Oct 28, 2021	BUY	$282.99 - $369.05 $1.74 Million - $2.27 Million	6,147 New	6,147 $1.74 Million
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $203,574 - $325,962	-786 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $190,958 - $223,719	786 New	786 $220,000
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $293,434 - $441,692	-1,242 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$264.77 - $305.71 $328,844 - $379,691	1,242 New	1,242 $352,000
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $778,307 - $1.03 Million	-3,009 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $808,969 - $1.03 Million	3,009 New	3,009 $952,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mizuho Markets Cayman LP, based on Form 13F filings with the SEC.

Stay updated on Mizuho Markets Cayman LP with notifications on news.